Tag: Cancer: Lymphoma
Jury Finds Roundup a Major Contributor to Man’s Cancer
Landmark verdict could impact hundreds of other similar lawsuits
Risk Factors ID’d for Diffuse Large B-Cell Lymphoma Mortality
In older patients, risk factors include advanced age, DLBCL stage, Charlson Comorbidity Index
Autologous Stem Cell Transplant May Aid Some With Nodal PTCL
Prospective cohort study suggests benefit of ASCT for some with nodal peripheral T-cell lymphoma
FDA: Number of U.S. Women With Breast Implant-Caused Cancer Has Increased
Textured implants linked to cases of anaplastic large cell lymphoma
Chemo-Radiation Combo Tied to Higher Survival in Peds Hodgkin
Five-year overall survival higher in patients who receive combined tx than those treated with chemo alone
Childhood Hodgkin Lymphoma Survivors at Risk for Later Cancers
Survivors have 14-fold increased risk for developing a solid subsequent malignant neoplasm
American Society of Hematology, Dec. 1-4
The 60th American Society of Hematology Annual Meeting and Exposition The annual meeting of the American Society of Hematology was held from Dec....
ASH: A+CHP Bests CHOP for Peripheral T-Cell Lymphoma
Median progression-free survival improved with A+CHP vs CHOP; similar incidence of adverse events
ASH: High Response to Tx After Checkpoint Blockade in NHL, HL
Immunotherapy boosts later therapy for relapsed, refractory non-Hodgkin, Hodgkin lymphoma
FDA Approves First Biosimilar to Non-Hodgkin’s Lymphoma Drug
Truxima approved to treat adults with CD20-positive, B-cell non-Hodgkin's lymphoma
